These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 29755921)

  • 1. A Comprehensive Review of Tourette Syndrome and Complementary Alternative Medicine.
    Kumar A; Duda L; Mainali G; Asghar S; Byler D
    Curr Dev Disord Rep; 2018; 5(2):95-100. PubMed ID: 29755921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Complementary and Alternative Medicine in Children With Tourette Syndrome.
    Patel H; Nguyen K; Lehman E; Mainali G; Duda L; Byler D; Kumar A
    J Child Neurol; 2020 Jul; 35(8):512-516. PubMed ID: 32233737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nutritional supplements and complementary/alternative medicine in Tourette syndrome.
    Mantel BJ; Meyers A; Tran QY; Rogers S; Jacobson JS
    J Child Adolesc Psychopharmacol; 2004; 14(4):582-9. PubMed ID: 15662150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complementary and alternative medicine use in Gilles de la Tourette syndrome.
    Kompoliti K; Fan W; Leurgans S
    Mov Disord; 2009 Oct; 24(13):2015-9. PubMed ID: 19705358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical effectiveness and patient perspectives of different treatment strategies for tics in children and adolescents with Tourette syndrome: a systematic review and qualitative analysis.
    Hollis C; Pennant M; Cuenca J; Glazebrook C; Kendall T; Whittington C; Stockton S; Larsson L; Bunton P; Dobson S; Groom M; Hedderly T; Heyman I; Jackson GM; Jackson S; Murphy T; Rickards H; Robertson M; Stern J
    Health Technol Assess; 2016 Jan; 20(4):1-450, vii-viii. PubMed ID: 26786936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tourette Syndrome and Comorbid Neuropsychiatric Conditions.
    Kumar A; Trescher W; Byler D
    Curr Dev Disord Rep; 2016; 3(4):217-221. PubMed ID: 27891299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dystonic motor and phonic tics in Tourette syndrome.
    Baizabal-Carvallo JF; Alonso-Juarez M; Jankovic J
    J Neurol; 2022 Oct; 269(10):5312-5318. PubMed ID: 35567613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Life events and Tourette syndrome.
    Steinberg T; Shmuel-Baruch S; Horesh N; Apter A
    Compr Psychiatry; 2013 Jul; 54(5):467-73. PubMed ID: 23219489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complex phonic tic and disinhibition in Tourette syndrome: case report.
    Maia DP; Cardoso F
    Arq Neuropsiquiatr; 2001 Sep; 59(3-A):587-9. PubMed ID: 11588640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Insights into Clinical Characteristics of Gilles de la Tourette Syndrome: Findings in 1032 Patients from a Single German Center.
    Sambrani T; Jakubovski E; Müller-Vahl KR
    Front Neurosci; 2016; 10():415. PubMed ID: 27672357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tourette syndrome in a longitudinal perspective. Clinical course of tics and comorbidities, coexisting psychopathologies, phenotypes and predictors.
    Groth C
    Dan Med J; 2018 Apr; 65(4):. PubMed ID: 29619935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin for motor and phonic tics in Tourette's syndrome.
    Pandey S; Srivanitchapoom P; Kirubakaran R; Berman BD
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD012285. PubMed ID: 29304272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Clinical Characterization of Blocking Tics in Patients With Tourette Syndrome.
    Baizabal-Carvallo JF; Jankovic J
    J Mov Disord; 2023 May; 16(2):163-167. PubMed ID: 36872859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adulthood outcome of tic and obsessive-compulsive symptom severity in children with Tourette syndrome.
    Bloch MH; Peterson BS; Scahill L; Otka J; Katsovich L; Zhang H; Leckman JF
    Arch Pediatr Adolesc Med; 2006 Jan; 160(1):65-9. PubMed ID: 16389213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aripiprazole for the treatment of Tourette syndrome.
    Cox JH; Cavanna AE
    Expert Rev Neurother; 2021 Apr; 21(4):381-391. PubMed ID: 33612035
    [No Abstract]   [Full Text] [Related]  

  • 16. Cannabis-based medicine in treatment of patients with Gilles de la Tourette syndrome.
    Szejko N; Saramak K; Lombroso A; Müller-Vahl K
    Neurol Neurochir Pol; 2022; 56(1):28-38. PubMed ID: 34708399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tourette's syndrome in adults.
    Jankovic J; Gelineau-Kattner R; Davidson A
    Mov Disord; 2010 Oct; 25(13):2171-5. PubMed ID: 20690167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacotherapy for tics in adult patients with Tourette syndrome and other tic disorders.
    Badenoch J; Cavanna AE
    Neurol Sci; 2020 Jul; 41(7):1923-1926. PubMed ID: 32170503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tourette Syndrome Treatment Updates: a Review and Discussion of the Current and Upcoming Literature.
    Frey J; Malaty IA
    Curr Neurol Neurosci Rep; 2022 Feb; 22(2):123-142. PubMed ID: 35107785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal course of the tourette syndrome clinical triad.
    Shprecher DR; Rubenstein LA; Gannon K; Frank SA; Kurlan R
    Tremor Other Hyperkinet Mov (N Y); 2014; 4():243. PubMed ID: 25295223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.